New Health Articles Sitemap
Home Articles Find Clinical Trials Health Directory
	Search:
	HOME > ARTICLES > DIABETES > PERIPHERAL-NEUROPATHY

Allergies The GE2 Molecule Dust Mite Destruction About Allergies Arthritis Arthritis and Acupuncture Arthritis and Gene Therapy Therapy and Bone Repair About Arthritis Osteoarthritis Rheumatoid Arthritis Automimmune diseases Autoimmune Diseases About Autoimmune Diseases Lupus Chinese Medicines Lupus Treatments Thrush primary immunodeficiency Thrush Bladder problems Transurethral Resection About Bladder Problems Overactive Bladder Treating Overactive Bladder Urinary Incontinence Causes Urinary Incontinence Urinary Tract Infections and Diet Urinary Tract Infections Blood and vascular disorders Warfarin and Vitamin K About Blood and Vascular Disorders Varicose Veins Risks Varicose Veins Waldenstroms Cancer HRT and Breast Cancer Research and Breast Cancer Food Prevention About Cancer Kidney Cancer Kidney Tumors Leiomyosarcoma Leukemia Survival Leukemia Liver Cancer Lung Cancer New Treatments Lung Cancer Lymphoma Actually Two Forms of Cancer Lymphoma Milk Treatment Mouth Cancer Oral Cancer Treatment Ovarian Cancer Ovarian Cancers Gene Mutations Pancreatic Cancer Protein Tumor Fighter Pancreatic Cancer Prostate Cancer Treatment Prostate Cancer Testicular Cancer Transplants Testicular Cancer Throat Cancer Your Voice Throat Cancer Uterine Cancer Detection Uterine Cancer Cholesterol Diet and Cholesterol Levels About Cholesterol Diabetes Diabetes in Children Diabetes Insipidus Diabetes Risk Diabetic Retinopathy About Diabetes Peripheral Neuropathy   Type 1 Diabetes Type 1 Treatment Type 2 Diabetes Type 2 Treatment Erectile dysfunction About Erectile Dysfunction Male Erectile Dysfunction Male Impotence Headaches About Headaches Migraine Aura Migraines Heart problems Heart and Home About Heart Problems Molecular Marker Sudden Coronary Death Vitamins Heart Disease Heartburn and gerd About Heartburn and GERD Herpes Cold Sores Genital Herpes and Technology About Herpes Genital Herpes Hypertension Causes and Symptoms Fighting Hypertension Angiostensin II Blockers Hypertension Medications Hypertension-Headaches About Hypertension Preventing Hypertension Intestinal problems Crohn's Disease Hormone Therapy About Intestinal Problems Irritable Bowel Syndrome Ulcerative Colitis Self Management Ulcerative Colitis Lung diseases Antibiotics and Cystic Fibrosis Causes of Asthma Corticosteriods Risks About Lung Diseases Obesity About Obesity Obesity Obesity and Food Osteoporosis Hormone Replacement Therapy About Osteoporosis Osteoporosis in Men Tea Caffeine Osteoporosis Pain About Pain New Class of Anti-Inflammatory Painkiller Nervous System Pain Management Cycles Pain Management evaluation Prostate problems Saw Palmetto and Finasteride Microwave Urethroplasty About Prostate Problems Prostate Disorders Psychiatric disorders Alcohol and Dementia New Molecule to Reduce Amyloid Depostis Screening Tools for Alzheimers Blood Flow and Alzheimers Alzheimer's and Caregivers Anemia & Dementia Anxiety and Perception Child Abuse and Depression Anxiety and the Adolescent Coping with Depression The Elderly About Psychiatric Disorders Parkinsons Disease Dopamine Parkinson's Disease Teen Health & Depression Teenage Depression Salivary glands About Salivary Glands Salivary Glands Research Salivary Glands Skin disorders Acne Causes Laser Treatments for Acne About Skin Disorders Psoriasis Treatment Psoriasis Rosacea Symptoms rosacea Skin Cancer Survival Skin Cancer Treatment Options Sleep Drugs Sleep Deprivation About Sleep Insomnia and Alcohol Insomnia and Tea Insomnia Sleep Disorders Narcolepsy Sleep Disorders Students Sleep Deprivation Turner syndrome About Turner Syndrome Turner Syndrome Growth Hormones Turner Syndrome Wellness Alternative Medicine About Wellness Start a Fitness Program Womens health Reluctance to Seek Help for FSD About Womens Health Intranasal Apomorphine HCl Menopause Symptom Relief Uterine Fibroids Treatment Uterine Fibroids

Systemic Contact Dermatitis: Diagnostic Challenges in 2002 The loss of sensation in limbs, hands, and feet is one of the three most serious side effects of diabetes. (The other two are diabetic retinopathy, which affects the eyes, and diabetic nephropathy, which impacts kidney function.) Known as diabetic peripheral neuropathy, or DPN, this condition affects the nerves in the extremities and can lead to tingling, numbness and pain and, in advanced cases, may require amputation of hands and feet. Until recently, there was not much hope of treating diabetic neuropathy once it began; only the traditional methods of controlling glucose and frequent examinations were available options. With over 150 million diabetics across the globe and projections that this figure could double in the next few years, developing a means of limiting and/or reversing DPN has become a critical issue. The implications of diabetic peripheral neuropathy reach far beyond the immediate human impact on the diabetic and his or her family; the social and economic implications, both in the United States and worldwide, are of grave significance as well. New research, however, has indicated that hope may well be on the horizon for diabetics who show symptoms of neuropathy. A new drug, LY333531, has demonstrated positive results in treating DPN. Research has established that PKC (protein kinase C) Beta, an enzyme produced in the body, is involved in the overall process that leads to diabetic neuropathy. The theory is that if PKC Beta production could be blocked, the effects of DPN might be slowed or even reversed. During a recent annual meeting of the American Diabetes Association, a team headed by Dr. Aaron Vinik announced significant results of recent clinical trials utilizing LY333531. In a yearlong clinical trial of the drug, Dr. Vinik and his team found improvement in DPN patients, as measured by neurological tests, physician evaluations and other objective tests of nerve functioning. Vinik and associates noted that, while elevated blood sugar found in people with diabetes triggers PKC Beta production, LY333531 was a positive factor in improved nerve function and other sensory measures. The group also felt that, based on these early trials, patients experiencing the early signs of diabetic neuropathy would benefit most from LY333531 treatment. More clinical trials for this medication are scheduled for this year and the next and the manufacturer of the drug, Eli Lilly, plans to seek FDA approval for its use as a treatment for diabetic neuropathy in 2004. Though still in the testing stage LY333531 promises a significant breakthrough in treatment for DPN and a positive impact in the lives of diabetic patients everywhere. References Business Wire. (2002, June 17). Data presented at ADA reveal Lilly's PKC Beta inhibitor improved symptomatic diabetic peripheral neuropathy: Lilly plans U.S. regulatory submission in 2004. Retrieved July 4, 2002, from http://www.businesswire.com/webbox/bw.061702/221682274.htm. Vinik, A., Tesfaye, S., Zhang, D., & Bastyr, E. (2002, June 17). LY333531 treatment improves diabetic peripheral neuropathy (DPN) with symptoms. Presented at 62nd Scientific Sessions of American Diabetes Association, San Francisco (abstract #321).

Ads by Yahoo! Byetta® (Exenatide) Injection. Learn more about the Byetta® support program. www.BYETTA.com Male With Diabetes? You may also have low testosterone. Click here to learn more. www.LearnAboutLowTestosterone.com Help for Diabetics Register Today To Stay Informed About Diabetes & Insulin- Free Gift www.WhyInsulin.com

	Home | About Us | Terms of Use | Privacy & Security | Site Map | © morefocus group, inc.